Trial Profile

Phase II/III trial of topical interferon-alpha 2b in patients with cervical dysplasia.

Status: Planning

Phase of Trial: Phase II/III

Latest Information Update: 15 Nov 2011

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Interferon alpha-2b (Primary)
Indications Cervical cancer; Cervical dysplasia
Focus Registrational; Therapeutic Use

Most Recent Events

11 Nov 2011 The US FDA removes a clinical hold on an IND application for this trial, according to a Helix BioPharma media release.
12 Oct 2011 Helix BioPharma has filed a complete response to the clinical hold, according to a Helix BioPharma media release.
19 Nov 2010 The FDA has placed a clinical hold on an IND for this trial, according to a Helix BioPharma media release.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com